A Phase 1 Study to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies)
Conditions: Healthy Volunteers Interventions: Drug: Atorvastatin; Drug: ALG-055009; Drug: Rosuvastatin Sponsors: Aligos Therapeutics Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants
Conditions: Healthy; Obese; Overweight Interventions: Drug: Orforglipron; Drug: Simvastatin; Drug: Digoxin; Drug: Rosuvastatin; Drug: Acetaminophen; Drug: Midazolam; Drug: Sodium Bicarbonate Sponsors: Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 1, 2024 Category: Research Source Type: clinical trials
Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention
Conditions: Coronary Artery Disease; Dyslipidemias; Primary Prevention Interventions: Drug: Combination drug group of Ezetimibe 10 mg/Rosuvastatin 5 mg; Drug: Mono drug group of Rosuvastatin 20 mg Sponsors: Saint Vincent ' s Hospital, Korea Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2023 Category: Research Source Type: clinical trials
A Clinical Trial to Evaluate JAB-21822 Drug-drug Interactions in Healthy Subjects
Conditions: Healthy Subjects Interventions: Drug: JAB-21822; Drug: Itraconazole; Drug: Omeprazole; Drug: Midazolam , Rosuvastatin calcium and digoxin; Drug: Rifampicin Sponsors: Jacobio Pharmaceuticals Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials
A Study to Investigate the Potential Drug Interactions Between ALXN2080 and Rosuvastatin and Metformin in Healthy Adult Participants
Conditions: Healthy Interventions: Drug: Metformin; Drug: Rosuvastatin; Drug: ALXN2080 Sponsors: Alexion Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Clinical Trial to Evaluate the Efficacy and Safety of Suvaro ®OD Tablet in Patients With Dyslipidemia
Conditions: Dyslipidemia Interventions: Drug: Rosuvastatin Immediate-Release Tablet (IRT) 10mg; Drug: Rosuvastatin orally disintegrating tablet (SUVARO ®ODT) 10mg Sponsors: Yonsei University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials
A Drug-Drug Interaction Study of LY3537982 on Midazolam, Digoxin, and Rosuvastatin in Healthy Participants
Conditions: Healthy Interventions: Drug: LY3537982; Drug: Digoxin; Drug: Rosuvastatin; Drug: Midazolam; Drug: Midazolam Sponsors: Eli Lilly and Company; Loxo Oncology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and Itraconazole or Omeprazole on PK of D-1553
Conditions: Healthy Male Interventions: Drug: D-1553 Sponsors: InventisBio Co., Ltd Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
Clinical Effects of New Approach on Patients With Non-alcoholic Steatohepatitis
Conditions: Non-alcoholic Steatohepatitis Interventions: Drug: Rosuvastatin 20mg; Drug: N-acetyl cysteine; Drug: Rosuvastatin and N-acetyl cysteine; Drug: Vita-E Sponsors: Beni-Suef University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Conditions: Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I Interventions: Drug: statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day); Sponsors: Peking University People ' s Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Statins in Patients With Spontaneous Intracerebral Hemorrhage
Conditions: Intracerebral Hemorrhage Interventions: Drug: Atorvastatin; Drug: Rosuvastatin; Other: No drugs Sponsors: Pomeranian Medical University Szczecin Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
A Drug-Drug Interaction Study Evaluating the Perpetrator Potential of DC-806 on Cocktails of CYP450 Enzyme and Transporter Substrates in Healthy Participants
Conditions: Healthy Participants Interventions: Drug: DC-806; Drug: Midazolam; Drug: Repaglinide; Drug: Digoxin; Drug: Rosuvastatin Sponsors: DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2023 Category: Research Source Type: clinical trials
A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin
Conditions: Healthy Volunteers Interventions: Drug: Obicetrapib; Drug: Atorvastatin Calcium; Drug: Rosuvastatin Calcium Sponsors: NewAmsterdam Pharma; Pharma Medica Research, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
Potential Drug Interaction Study Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel/Ethinyl Estradiol-containing Oral Contraceptives, and Carbamazepine
Conditions: Healthy Participants Interventions: Drug: Vemircopan; Drug: Rosuvastatin; Drug: Metformin; Drug: Levonorgestrel / Ethinyl Estradiol; Drug: Carbamazepine Sponsors: Alexion Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 6, 2023 Category: Research Source Type: clinical trials
Comparison Between Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients With Acute Coronary Syndrome
Condition: Mi Q Wave Interventions: Device: Turbox CRP kit; Drug: rosuvastatin 20 mg,; Drug: atorvastatin 40 mg Sponsor: Rawalpindi Medical College Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
